Biblio Discovery — Demo Discovery Service

4 results for "Ana Gervassi"

Showing 1–4 · 0.34 seconds · RSS

  1. Journal Article Full text

    Myeloid Derived Suppressor Cells Are Present at High Frequency in Neonates and Suppress In Vitro T Cell Responses

    Ana Gervassi; Nicholas Lejarcegui; Sandra Dross et al.

    PLoS ONE, Vol. 9 No. 9 · 2014 · English · PLOS Scopus

    Over 4 million infants die each year from infections, many of which are vaccine-preventable. Young infants respond relatively poorly to many infections and vaccines, but the basis of reduced immunity in infants is ill defined. We sought to investigate whether myeloid-derived suppressor cells (MDSC)…

  2. Journal Article Full text

    Observational study of effects of HIV acquisition and antiretroviral treatment on biomarkers of systemic immune activation

    Ewelina Kosmider; Jackson Wallner; Ana Gervassi et al.

    PLOS ONE, Vol. 19 No. 7 · 2024 · English · PLOS Scopus

    To assess whether biomarkers of systemic inflammation are associated with HIV acquisition or with the timing of ART initiation (“immediate”, at diagnosis, versus “deferred”, at 24 weeks post-diagnosis) in men-who-have-sex-with-men (MSM) and transgender women, we conducted a retrospective study…

  3. Journal Article Full text

    Low rate of SARS-CoV-2 incident infection identified by weekly screening PCR in a prospective year-long cohort study

    Whitney E. Harrington; Winnie Yeung; Ingrid A. Beck et al.

    PLOS ONE, Vol. 17 No. 9 · 2022 · English · PLOS Scopus

    Background: Asymptomatic and pre-symptomatic SARS-CoV-2 infections may contribute to ongoing community transmission, however, the benefit of routine screening of asymptomatic individuals in low-risk populations is unclear. Methods: To identify SARS-CoV-2 infections 553 seronegative individuals were…

  4. Journal Article Full text

    Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection

    Yonghou Jiang; Fergal Duffy; Jennifer Hadlock et al.

    PLOS ONE, Vol. 16 No. 11 · 2021 · English · PLOS Scopus

    Background: Coronavirus disease 2019 (COVID-19) is associated with endothelial activation and coagulopathy, which may be related to pre-existing or infection-induced pro-thrombotic autoantibodies such as those targeting angiotensin II type I receptor (AT1R-Ab). Methods: We compared prevalence and…